Review Article
Vascular Homeostasis and Angiogenesis Determine Therapeutic Effectiveness in Type 2 Diabetes
Table 2
A predominant role of VEGFR2 correlates with PTCF reduction in late stage of DN.
| | Vascular homeostasis | | Renal hemodynamics |
| | Early DN | | Normal | | Early DN | | Normal | VEGF R1 ng/mL | 60±12 | NS | 49 ± 5 | PTCF mL/min/1.73m2 | 379 ± 70 | <.05 | 483 ± 43 | VEGF R2 ng/mL | 5715 ± 1400 | NS | 6126 ± 1066 |
| | Late DN | | Normal | | Late DN | | Normal | VEGF R1 ng/mL | 33 ± 17 | <.01 | 55 ± 11 | PTCF mL/min/1.73m2 | 277 ± 80 | <.001 | 483 ± 43 | VEGF R2 ng/mL | 10414 ± 2198 | <.01 | 7696 ± 1892 |
|
|